From: PAX1 hypomethylation as a prognostic biomarker for radioresistance of cervical cancer
Characteristics | Univariate analysis | Multivariate analysis | ||||||
---|---|---|---|---|---|---|---|---|
β | OR | 95% CI | P | β | OR | 95% CI | P | |
Age (year) | − 0.007 | 0.993 | 0.951–1.038 | 0.757 |  |  |  |  |
FIGO stage | 0.476 | 1.610 | 0.325–7.984 | 0.560 |  |  |  |  |
Pathology | 1.736 | 5.677 | 0.990–32.542 | 0.051 | 2.011 | 7.473 | 1.011–55.254 | 0.049* |
Lymph nodes | 1.764 | 5.833 | 2.466–13.797 | < 0.001* | 1.049 | 2.854 | 1.067–7.638 | 0.037* |
HPV16/18 | − 0.015 | 0.985 | 0.425–2.286 | 0.973 |  |  |  |  |
Anemia | 0.405 | 1.500 | 0.674–3.339 | 0.321 |  |  |  |  |
Tumor size | 0.039 | 1.040 | 1.019–1.062 | < 0.001* | 0.037 | 1.038 | 1.014–1.062 | 0.002* |
PAX1 hypomethylation | 1.257 | 3.513 | 1.165–10.590 | 0.026* | 1.489 | 4.433 | 1.131–17.380 | 0.033* |